These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 10468094)

  • 1. Effect of vasoactive therapy on heart rate variability in patients with acutely decompensated congestive heart failure.
    Burger AJ; Aronson D
    Am J Cardiol; 1999 Aug; 84(4):476-8, A10. PubMed ID: 10468094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of autonomic tone over a 24-hour period in patients with congestive heart failure: relation between mean heart rate and measures of heart rate variability.
    Panina G; Khot UN; Nunziata E; Cody RJ; Binkley PF
    Am Heart J; 1995 Apr; 129(4):748-53. PubMed ID: 7900627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Choice for the treatment of congestive heart failure].
    J Cardiol Suppl; 1989; 20():53-6. PubMed ID: 2557870
    [No Abstract]   [Full Text] [Related]  

  • 4. Digitalis therapy for patients in clinical heart failure.
    Rahimtoola SH
    Circulation; 2004 Jun; 109(24):2942-6. PubMed ID: 15210610
    [No Abstract]   [Full Text] [Related]  

  • 5. Role of spectral measures of heart rate variability as markers of disease progression in patients with chronic congestive heart failure not treated with angiotensin-converting enzyme inhibitors.
    Panina G; Khot UN; Nunziata E; Cody RJ; Binkley PF
    Am Heart J; 1996 Jan; 131(1):153-7. PubMed ID: 8554003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of levosimendan on ventricular arrhythmias and prognostic autonomic indexes in patients with decompensated advanced heart failure secondary to ischemic or dilated cardiomyopathy.
    Flevari P; Parissis JT; Leftheriotis D; Panou F; Kourea K; Kremastinos DT
    Am J Cardiol; 2006 Dec; 98(12):1641-5. PubMed ID: 17145226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Congestive heart failure--pathophysiology and medical treatment.
    Remme WJ
    J Cardiovasc Pharmacol; 1986; 8 Suppl 1():S36-52. PubMed ID: 2422492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heart rate behaviour at different stages of congestive heart failure.
    Stefenelli T; Bergler-Klein J; Globits S; Pacher R; Glogar D
    Eur Heart J; 1992 Jul; 13(7):902-7. PubMed ID: 1644079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of flosequinan on autonomic tone in congestive heart failure: implications for the mechanism of the positive chronotropic effect and survival influence of long-term vasodilator administration.
    Binkley PF; Nunziata E; Cody RJ
    Am Heart J; 1994 Dec; 128(6 Pt 1):1147-56. PubMed ID: 7985595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nesiritide vs nitroglycerin for decompensated congestive heart failure.
    Dunavant S
    JAMA; 2002 Aug; 288(5):571-2; author reply 572-3. PubMed ID: 12150661
    [No Abstract]   [Full Text] [Related]  

  • 11. Cardiac failure XIV. Treatment by modification of circulatory dynamics.
    Cohn JN
    Hosp Pract (Off Ed); 1984 Aug; 19(8):37-52. PubMed ID: 6430933
    [No Abstract]   [Full Text] [Related]  

  • 12. Vasodilator therapy for decompensated heart failure.
    Yancy CW
    J Am Coll Cardiol; 2008 Jul; 52(3):208-10. PubMed ID: 18617069
    [No Abstract]   [Full Text] [Related]  

  • 13. Nesiritide vs nitroglycerin for decompensated congestive heart failure.
    Rifkin W
    JAMA; 2002 Aug; 288(5):572; author reply 572-3. PubMed ID: 12150662
    [No Abstract]   [Full Text] [Related]  

  • 14. The use of vasoactive therapy for acute decompensated heart failure: hemodynamic and renal considerations.
    Heywood JT; Khan TA
    Rev Cardiovasc Med; 2007; 8 Suppl 5():S22-9. PubMed ID: 18192950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early vasoactive drugs improve heart failure outcomes.
    Peacock WF; Emerman C; Costanzo MR; Diercks DB; Lopatin M; Fonarow GC
    Congest Heart Fail; 2009; 15(6):256-64. PubMed ID: 19925503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of nesiritide (B-type natriuretic peptide) and dobutamine on ventricular arrhythmias in the treatment of patients with acutely decompensated congestive heart failure: the PRECEDENT study.
    Burger AJ; Horton DP; LeJemtel T; Ghali JK; Torre G; Dennish G; Koren M; Dinerman J; Silver M; Cheng ML; Elkayam U;
    Am Heart J; 2002 Dec; 144(6):1102-8. PubMed ID: 12486437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New concepts and drugs in the treatment of congestive heart failure.
    Friedman WF; George BL
    Pediatr Clin North Am; 1984 Dec; 31(6):1197-227. PubMed ID: 6390312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. Nesiritide Study Group.
    Colucci WS; Elkayam U; Horton DP; Abraham WT; Bourge RC; Johnson AD; Wagoner LE; Givertz MM; Liang CS; Neibaur M; Haught WH; LeJemtel TH
    N Engl J Med; 2000 Jul; 343(4):246-53. PubMed ID: 10911006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circadian and power spectral changes of RR and QT intervals during treatment of patients with angina pectoris with nadolol providing evidence for differential autonomic modulation of heart rate and ventricular repolarization.
    Sarma JS; Singh N; Schoenbaum MP; Venkataraman K; Singh BN
    Am J Cardiol; 1994 Jul; 74(2):131-6. PubMed ID: 8023776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of nesiritide (human b-type natriuretic peptide) and dobutamine on heart rate variability in decompensated heart failure.
    Aronson D; Burger AJ
    Am Heart J; 2004 Nov; 148(5):e16. PubMed ID: 15523294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.